Cargando…

Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia

BACKGROUND: Generic health-related quality of life (HRQoL) scales are increasingly being used to assess the effects of new treatments in schizophrenia. The objective of this study is to better understand the usefulness of generic and condition specific HRQoL scales in schizophrenia by analyzing thei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domenech, Cristina, Pastore, Adriana, Altamura, A Carlo, Bernasconi, Corrado, Corral, Ricardo, Elkis, Helio, Evans, Jonathan, Malla, Ashok, Margari, Francesco, Krebs, Marie-Odile, Nordstroem, Anna-Lena, Zink, Mathias, Haro, Josep Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930014/ https://www.ncbi.nlm.nih.gov/pubmed/31908462 http://dx.doi.org/10.2147/NDT.S218578

Ejemplares similares

S118. CAN THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) DIFFERENTIATE REFRACTORY FROM NON-REFRACTORY SCHIZOPHRENIA? A FACTOR ANALYTIC INVESTIGATION BASED ON DATA FROM THE PATTERN COHORT STUDY
por: de Freitas, Rosana, et al.
Publicado: (2018)

Schizophrenia Outpatient Health Outcomes study: twelve-month findings
por: Novick, Diego, et al.
Publicado: (2012)

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study
por: Malla, Ashok, et al.
Publicado: (2016)

T55. DRIVING ABILITIES IN CLINICALLY STABLE OUTPATIENTS WITH SCHIZOPHRENIA
por: Biedermann, Falko, et al.
Publicado: (2018)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
por: Hong, Jihyung, et al.
Publicado: (2012)

Cognitive Performance associated to functional outcomes in stable outpatients with schizophrenia
por: Zaragoza Domingo, Silvia, et al.
Publicado: (2015)

Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study
por: Brugnoli, Roberto, et al.
Publicado: (2012)

M184. SOCIAL SKILLS TRAINING FOR TREATMENT-RESISTANT SCHIZOPHRENIA WITH PREDOMINANTLY NEGATIVE SYMPTOMS
por: Kayo, Monica, et al.
Publicado: (2020)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum, Haya, et al.
Publicado: (2014)

EPICOG-SCH: A brief battery to screen cognitive impact of schizophrenia in stable outpatients()
por: Zaragoza Domingo, Silvia, et al.
Publicado: (2017)

Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment
por: Zink, Mathias
Publicado: (2014)

Treatment-resistant Schizophrenia: Evidence-based Strategies
por: Englisch, Susanne, et al.
Publicado: (2012)

Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
por: Koga, Gabriela, et al.
Publicado: (2022)

S193. EFFICACY AND SAFETY OF TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE FOLLOW-UP PHASE
por: Valiengo, Leandro, et al.
Publicado: (2020)

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study
por: Novick, Diego, et al.
Publicado: (2015)

Clozapine-Induced Obsessive-Compulsive Symptoms in Schizophrenia: A Critical Review
por: Schirmbeck, Frederike, et al.
Publicado: (2012)

Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors
por: Schirmbeck, Frederike, et al.
Publicado: (2013)

M40. ECT VERSUS SHAM FOR CLOZAPINE RESISTANT SCHIZOPHRENIA: A SECONDARY ANALYSIS OF A PILOT STUDY BASED ON PANSS-30 FACTOR ANALYTIC DIMENSIONS AND THE PANSS-6
por: Luciana Melzer-Ribeiro, Debora, et al.
Publicado: (2020)

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences
por: Dal Santo, Francesco, et al.
Publicado: (2020)

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã, Mário Rodrigues, et al.
Publicado: (2011)

Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists
por: Lutgens, Danyael, et al.
Publicado: (2013)

Impulsivity and Sensation Seeking in Alcohol Abusing Patients with Schizophrenia
por: Dervaux, Alain, et al.
Publicado: (2010)

Altered emotional modulation of associative memory in first episode schizophrenia: An fMRI study
por: Luck, David, et al.
Publicado: (2015)

Very early onset and greater vulnerability in schizophrenia: A clinical and neuroimaging study
por: Margari, Francesco, et al.
Publicado: (2008)

Evaluation of treatment adherence in outpatients with schizophrenia
por: Chaudhari, Bhushan, et al.
Publicado: (2017)

F119. MULTILEVEL ANALYSIS IMPROVES THE MODEL FIT OF THE DIMENSIONAL STRUCTURE OF THE PANSS IN PATIENTS WITH SCHIZOPHRENIA
por: Higuchi, Cinthia, et al.
Publicado: (2018)

The Role of the Cerebellum in Schizophrenia: an Update of Clinical, Cognitive, and Functional Evidences
por: Picard, Hernàn, et al.
Publicado: (2008)

Adjunctive antidepressive pharmacotherapy in schizophrenia patients
por: Zink, M.
Publicado: (2021)

S135. THE PSYCHOSIS CONTINUUM IN ELDERLY NON DEMENTED PERSONS: EVIDENCE DERIVED FROM PSYCHOTIC SYMPTOMS IN OLDER PEOPLE WITHOUT DEMENTIA FROM A BRAZILIAN COMMUNITY-BASED SAMPLE: A SEVEN YEARS’ FOLLOW-UP
por: Soares, Walter, et al.
Publicado: (2018)

Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
por: Petruzzelli, Maria Giuseppina, et al.
Publicado: (2020)

Disability in clinically stable patients of schizophrenia
por: Sharma, Mahaprakash, et al.
Publicado: (2020)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
por: Marcus, Steven C., et al.
Publicado: (2008)

Does lack of improvement in the first two weeks predict treatment resistance in recent-onset psychosis?
por: Kayo, Monica, et al.
Publicado: (2012)

Cognitive Training for Schizophrenia in Developing Countries: A Pilot Trial in Brazil
por: Pontes, Livia M. M., et al.
Publicado: (2013)

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
por: Balcar, Lorenz, et al.
Publicado: (2023)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick, Diego, et al.
Publicado: (2016)

Overconfidence in incorrect perceptual judgments in patients with schizophrenia
por: Moritz, Steffen, et al.
Publicado: (2014)

A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
por: Attux, Cecília, et al.
Publicado: (2013)

Familial liability, obstetric complications and childhood development abnormalities in early onset schizophrenia: a case control study
por: Margari, Francesco, et al.
Publicado: (2011)

F125. POOR OUTCOME SCHIZOPHRENIA (KRAEPELINIAN SUB-TYPE): SOCIAL COGNITIVE AND NEURODEVELOPMENTAL MARKERS
por: Chevallier, Emmanuel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jvm1ugb8d71hdpudrj66b453gk